Researchers Develop Drug-Like Molecules to Improve Schizophrenia Treatment
Wednesday, September 21, 2011 - 14:30
in Health & Medicine
Researchers at Vanderbilt University have identified chemical compounds that could lead to a major advance in the treatment of schizophrenia. In a transaction announced this week, Vanderbilt has licensed the compounds to Karuna Pharmaceuticals in Boston, Mass., for further development leading to human testing.